Search results
AbbVie (ABBV) Starts Late-Stage Study on Multiple Myeloma Drug
Zacks via Yahoo Finance· 8 hours agoThe late-stage study will evaluate AbbVie's (ABBV) experimental antibody to treat patients with...
Regeneron (REGN) Presents Positive Data on MM and FL Drugs
Zacks via Yahoo Finance· 1 year agoRegeneron Pharmaceuticals, Inc. REGN announced positive initial data from a mid-stage study on...
AbbVie treats first subject in Phase III multiple myeloma drug trial
Clinical Trials Arena via Yahoo Finance· 15 hours agoAbbVie has treated the first subject in the Phase III CERVINO clinical trial of its investigational...
Regeneron (REGN) Posts Positive Data on Blood Cancer Candidate
Zacks via Yahoo Finance· 6 months agoRegeneron Pharmaceuticals, Inc. REGN announced positive results from the phase I/II study on its...
Roche's (RHHBY) Hemophilia A Drug Gets Positive CHMP Opinion
Zacks via Yahoo Finance· 1 year agoRoche RHHBY announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products...
CytomX Therapeutics, Inc. (NASDAQ:CTMX) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 month agoCytomX Therapeutics, Inc. (NASDAQ:CTMX) Q1 2024 Earnings Call Transcript May 8, 2024 CytomX...
Pharma Stock Roundup: FDA Okays PFE & JNJ Drugs, EU Approves ABBV's Migraine Drug
Zacks via Yahoo Finance· 10 months agoFDA approves Pfizer's (PFE) Elrexfio (elranatamab) for RRMM and J&J's (JNJ) oral combination tablet,...
Pharma Stock Roundup: AZN's Small Cancer Firm Buyout, FDA Updates for PFE, RHHBY
Zacks via Yahoo Finance· 2 years agoThis week, the FDA granted priority review status to Roche’s RHHBY regulatory application for...
Q4 2023 CytomX Therapeutics Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 3 months agoParticipants Chris Ogden; SVP, Finance and Accounting; CytomX Therapeutics Inc Sean McCarthy; CEO & Chairman; CytomX Therapeutics Inc Joe Catanzaro; Analyst; Piper Sandler & Co Anupam Rama; ...
BioAtla, Inc. (NASDAQ:BCAB) Q4 2022 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 year agoBioAtla, Inc. (NASDAQ:BCAB) Q4 2022 Earnings Call Transcript March 23, 2023 Operator: Greetings. And...